Hims & Hers Health (HIMS) Exchange Rate Effect (2020 - 2026)
Hims & Hers Health (HIMS) reported Exchange Rate Effect of -$2.4 million for Q1 2026, down 1079.42% on a YoY basis from $243000.0 in Q1 2025, and down 187.37% sequentially from $2.7 million in Q4 2025.
Hims & Hers Health (HIMS) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 7 years of Exchange Rate Effect data on file, last reported at -$2.4 million in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 1079.42% year-over-year to -$2.4 million; the trailing twelve-month figure through Mar 2026 stood at -$115000.0 (down 296.55% YoY), and the FY2025 full-year result was $2.5 million, up 1028.89% from the prior year.
- Exchange Rate Effect retreated to -$2.4 million in Q1 2026, from $2.7 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $2.7 million in Q4 2025 to a low of -$2.4 million in Q1 2026.
- A 5-year average of -$12117.6 and a median of $2000.0 in 2024 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect slumped 1250.0% in 2022 and jumped 102800.0% in 2025, its largest moves.
- Tracing HIMS's Exchange Rate Effect over 5 years: stood at -$17000.0 in 2022, then plunged by 182.35% to -$48000.0 in 2023, then sank by 860.42% to -$461000.0 in 2024, then surged by 690.89% to $2.7 million in 2025, then plunged by 187.37% to -$2.4 million in 2026.
- Business Quant data shows HIMS's Exchange Rate Effect at -$2.4 million in Q1 2026, $2.7 million in Q4 2025, and -$1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Hims & Hers Health | 7.48 Bn | 6.73 Bn | 396.79 Mn | -2.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.38 Mn |
| Mar 31, 2026 | -2.38 Mn |
| Dec 31, 2025 | 2.72 Mn |
| Dec 31, 2025 | 2.72 Mn |
| Sep 30, 2025 | -1.49 Mn |
| Sep 30, 2025 | -1.49 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 243,000.00 |
| Mar 31, 2025 | 243,000.00 |
| Dec 31, 2024 | -461,000.00 |
| Dec 31, 2024 | -461,000.00 |
| Sep 30, 2024 | 190,000.00 |
| Sep 30, 2024 | 190,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | -48,000.00 |
| Dec 31, 2023 | -48,000.00 |